Argent Trading, Inc. was founded in 1958 and is based in New York, New York with additional offices in Belgium, Brazil, Bulgaria, China, Columbia, France, Germany, Greece, India, Italy, Mexico, Portugal, Romania, South Korea, Spain, Turkey, the United Arab Emirates, the United Kingdom, and the United States. Argent Trading Inc., a corporate trading company, purchases underperforming assets using its trading currency, Asset Purchase Credits (APC's) in the United States and internationally. The company provides trading solutions, including real estate and remarketing solutions, as well as helps clients to use trade credits in various media vehicles. Its client companies use their APC's towards the purchase of budgeted goods and services, including media, manufacturing materials, capital equipment, packaging, transportation, distribution, and sales and administrative expenses.

Argosy Private Equity business, the investment firm focuses on buyouts, recapitalizations, and financing of middle-market firms in the eastern half of the US with annual sales between $15 million and $100 million. The company prefers to invest in smaller firms with room for growth, and it provides them not only with capital, but operational support and strategic planning. Typical investments range from $3 million to $9 million per transaction. Its portfolio contains stakes in some 35 companies, mainly in the manufacturing, industrial electronics, and industrial and business services sectors.

ARQUES Industries AG was founded in 2003 and is based in Munich, Germany. ARQUES Industries AG is a private equity firm specializing in the acquisition, turnaround, and restructuring of companies in distress or generating losses. The firm seeks to invest in the acquisition of companies in special situations such as unresolved successor issues, modernization, and corporate spin-offs. It also invests in situations such as successional issues, technological change: economic problems due to neglect of important investments in the modernization of the enterprise, and classical turnaround situations due to inefficient structures/processes or incorrect management. The firm prefers to buy and build companies in difficult transitional situation through direct or indirect equity investments in corporate spinoffs and though the acquisition of small to medium sized companies. It has no specific industry preference and seeks to invest in relevant opportunities in all industries. The firm prefers to invest in companies with revenues between €30 million ($39.64 million) to €1000 million ($1321.58 million).

Arsenal Capital Partners, Inc. was founded in 2000 and is based in New York, New York with an additional office in Shanghai, China. Arsenal Capital Partners, Inc. is a private equity firm specializing in buyout, recapitalization, and growth equity investments in the middle market companies. The firm typically invests in information technology, healthcare, specialty industrial and financial services companies. Within healthcare, it focuses on manufacturing and service companies within pharmaceutical, medical devices, and healthcare services markets such as contract research, manufacturing, and testing services, medical and diagnostic devices and supplies, specialty distribution and logistics, alternative site care providers, healthcare information technology, and outsourced services to payors and providers. Within specialty industrial, the firm focuses on providers of specialty products and services across a range of sectors such as specialty chemicals and materials, aerospace and defense, transportation and logistics, outsourced industrial services, specialty packaging, and environmental products and services.

Ascendant Solutions, Inc. was founded in 1997. Ascendant Solutions, Inc. ("Ascendant") is a value oriented investment firm focused on making equity investments in underperforming or distressed U.S. lower middle-market businesses. Ascendant is primarily interested in investing or acquiring, in manufacturing, distribution, service, healthcare, finance and retail industries with $20 to $150 million in annual revenues that require access to capital or capital restructuring, and strategic support to improve operational performance. Ascendant currently has approximately $40 million in net operating loss carryforwards, which can be used to shelter future income, thus enhancing free cash flow or debt service capabilities.

Asset Value Investors was established in 1985. Asset Value Investors (formerly Ivory & Sime Asset Management) wants to increase the value of investors' assets. The UK firm primarily manages a handful of funds, which invest in a variety of assets. British Empire Securities and General Trust plc is a closed-end investment trust, while The European Asset Value Fund allows investors to participate in listed European property. Asset Value Investors company also manages the CF Asset Value Global Investors Fund, which focuses on foreign undervalued stocks, and AVI Value Fund, a US endowment portfolio. Funds under management total more than $3.4 billion.

Astaire Group Plc is a United Kingdom-based company. Its principal activities include investment banking, private client stock broking and wealth management. It has two divisions: Investment banking, and Private client and wealth management. Investment banking is engaged in London-based corporate finance, corporate broking and United Kingdom and international equities business. Private client and wealth management is engaged in the London and South West-focused branch network of executives providing personalized stock broking and wealth management services to individuals, charities and pension funds. During the year ended December 31, 2009, the Company sold its Australian business, Inteq Limited. On July 22, 2009, it has acquired Ruegg & Co Limited and on October 23, 2009 it has acquired Dowgate Capital Plc.

Astellas Venture Management invests in seed-stage and emerging biotech companies, including drug discovery and development companies. The firm manages four venture funds, and its portfolio includes more than 20 companies. Astellas Venture Management is the venture capital arm of Astellas Pharma, formed from the 2005 merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical. Astellas Venture Management provides its portfolio companies not only with cash, but also access to the scientific expertise, production facilities, and marketing clout of its parent firm.

Astellas Venture Management invests in seed-stage and emerging biotech companies, including drug discovery and development companies. The firm manages four venture funds, and its portfolio includes more than 20 companies. Astellas Venture Management is the venture capital arm of Astellas Pharma, formed from the 2005 merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical. Astellas Venture Management provides its portfolio companies not only with cash, but also access to the scientific expertise, production facilities, and marketing clout of its parent firm.

Aston Hill Financial Inc. (AHF) is a publicly owned investment manager. The firm also provides advisory services to its clients. It primarily provides its services to high net worth individuals and institutional investors. The firm manages equity and fixed income portfolios and advises funds of hedge funds for its clients. It invests in public equity, fixed income, and alternative investments markets across the globe. For its fixed income securities, the firm typically invests in collateralized debt obligations. It primarily makes its alternative investments in private equity and hedge funds. The firm employs a bottom-up stock picking approach to make its investments. It primarily invests in companies operating in the oil and gas, energy, and income trust sectors.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.